ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

NCI director says rules hurt retention, recruitment, cites Liotta’s departure.

April 8, 2005

Researchers Link Cancer Risk And DMPA Birth Control Use

April 27, 2012

Decision to Cover New Colorectal Cancer Drugs, PET Scans.

February 4, 2005

Women Surgeons: We Need Answers On Tamoxifin Now

May 13, 1994

NCI Encourages IP Chemo For Stage III Ovarian Cancer

January 27, 2006

Boundary; Opponents Of CMS Policy Step Up The Fight.

November 9, 2007